Home |
News & Events |
IDEA News |
Anti-rejection drug used in organ transplants protects patients from Alzheimer's
Individuals who underwent organ transplant are given a treatment to prevent the body from rejecting the transplanted organ.
Now, findings of a new study conducted by researchers from the University of Texas Medical Branch at Galveston suggest that the drug could also provide protection against Alzheimer's disease.